Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anthony Williams

Showing results (111-120 of 125) with videos related to

Pageof 13
Sort By:
Cancer Letters|May 11, 2023
SOX2 expression in prostate cancer drives resistance to nuclear hormone receptor signaling inhibition through the WEE1/CDK1 signaling axisAnthony Williams, Lisa Gutgesell, Larischa de Wet, et al.
Respiratory Research|February 21, 2018
Relationship of CT-quantified emphysema, small airways disease and bronchial wall dimensions with physiological, inflammatory and infective measures in COPDKristoffer Ostridge, Nicholas P Williams, Viktoriya Kim, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 16, 2015
Clinical and biological effects of an agonist anti-CD40 antibody: a Cancer Research UK phase I studyPeter Johnson, Ruth Challis, Ferdousi Chowdhury, et al.
Thorax|April 23, 2017
A prospective, observational cohort study of the seasonal dynamics of airway pathogens in the aetiology of exacerbations in COPDTom M A Wilkinson, Emmanuel Aris, Simon Bourne, et al.
Respiratory Research|July 30, 2018
Impact of radiologically stratified exacerbations: insights into pneumonia aetiology in COPDNicholas P Williams, Kristoffer Ostridge, Jeanne-Marie Devaster, et al.
Oncogene|February 11, 2022
Correction to: SOX2 mediates metabolic reprogramming of prostate cancer cellsLarischa de Wet, Anthony Williams, Marc Gillard, et al.
Oncogene|January 24, 2022
SOX2 mediates metabolic reprogramming of prostate cancer cellsLarischa de Wet, Anthony Williams, Marc Gillard, et al.
Thorax|September 30, 2022
Web-based physical activity promotion in young people with CF: a randomised controlled trialNarelle S Cox, Beverley Eldridge, Sarah Rawlings, et al.
Journal of Clinical Immunology|January 17, 2024
Management of Atopy with Dupilumab and Omalizumab in CADINS DiseaseNatalie M Diaz-Cabrera, Bradly M Bauman, Mildred A Iro, et al.
Eclinicalmedicine|May 9, 2020
A phase 1b randomized study of the safety and immunological responses to vaccination with H4:IC31, H56:IC31, and BCG revaccination in <i>Mycobacterium tuberculosis</i>-uninfected adolescents in Cape Town, South AfricaLinda-Gail Bekker, One Dintwe, Andrew Fiore-Gartland, et al.
Pageof 13

Showing results (111-120 of 125) with videos related to

Sort By:
Pageof 13
Cancer Letters|May 11, 2023
SOX2 expression in prostate cancer drives resistance to nuclear hormone receptor signaling inhibition through the WEE1/CDK1 signaling axisAnthony Williams, Lisa Gutgesell, Larischa de Wet, et al.
Respiratory Research|February 21, 2018
Relationship of CT-quantified emphysema, small airways disease and bronchial wall dimensions with physiological, inflammatory and infective measures in COPDKristoffer Ostridge, Nicholas P Williams, Viktoriya Kim, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 16, 2015
Clinical and biological effects of an agonist anti-CD40 antibody: a Cancer Research UK phase I studyPeter Johnson, Ruth Challis, Ferdousi Chowdhury, et al.
Thorax|April 23, 2017
A prospective, observational cohort study of the seasonal dynamics of airway pathogens in the aetiology of exacerbations in COPDTom M A Wilkinson, Emmanuel Aris, Simon Bourne, et al.
Respiratory Research|July 30, 2018
Impact of radiologically stratified exacerbations: insights into pneumonia aetiology in COPDNicholas P Williams, Kristoffer Ostridge, Jeanne-Marie Devaster, et al.
Oncogene|February 11, 2022
Correction to: SOX2 mediates metabolic reprogramming of prostate cancer cellsLarischa de Wet, Anthony Williams, Marc Gillard, et al.
Oncogene|January 24, 2022
SOX2 mediates metabolic reprogramming of prostate cancer cellsLarischa de Wet, Anthony Williams, Marc Gillard, et al.
Thorax|September 30, 2022
Web-based physical activity promotion in young people with CF: a randomised controlled trialNarelle S Cox, Beverley Eldridge, Sarah Rawlings, et al.
Journal of Clinical Immunology|January 17, 2024
Management of Atopy with Dupilumab and Omalizumab in CADINS DiseaseNatalie M Diaz-Cabrera, Bradly M Bauman, Mildred A Iro, et al.
Eclinicalmedicine|May 9, 2020
A phase 1b randomized study of the safety and immunological responses to vaccination with H4:IC31, H56:IC31, and BCG revaccination in <i>Mycobacterium tuberculosis</i>-uninfected adolescents in Cape Town, South AfricaLinda-Gail Bekker, One Dintwe, Andrew Fiore-Gartland, et al.
Pageof 13